Societal CDMO Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
EXTON, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a…
EXTON, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a…
Signs Agreement for $39 Million Sale and Leaseback Transaction with Tenet Equity; Proceeds to be…
Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa Positive…
PRESS RELEASE Emergex Generates Chikungunya Ligandome, a Milestone in the Development of its T cell…
Sino Biological Levit Green Houston, TX, Nov. 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Sino…
One month after a 30-µg booster dose of the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine, neutralizing…
NEW YORK and MAINZ, GERMANY, NOVEMBER 16, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech…
LONDON and PHOENIX, Nov. 16, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT), a…
§ 89% increase in Q3/2022 quarterly revenues as compared with Q3/2021 § Earnings and business update call…
Quadram RevoluGen Steven Rudder, a PhD student in Gemma Langridge’s research group at the Quadram…
– Can now test 1,000 employees across six sites as required, with each test always…
– Eastern Airways to use portable, hygienic, non-invasive fingerprint sweat test to support new European…
Novozymes delivered 9% organic sales growth in the first nine months of 2022 and 6%…
Agreement is expected to optimize handling and shipment processes and reduce direct sales costs TEL…
Goldstar Transport to Remove Urine Testing for Sweat Based Technology NEW YORK, Oct. 31, 2022…
Prescription Drug User Fee Act (PDUFA) goal date of August 29, 2023 ISELIN, N.J., Oct….
– Name change to more closely reflect firm’s expanding portfolio of intelligent, efficient, convenient and…
Agreements Showcase Company’s Ability to Support Novel Therapeutic Programs Regardless of Development Stage; Services Focused…
Agreements Showcase Company’s Ability to Support Novel Therapeutic Programs Regardless of Development Stage; Services Focused…
NEW YORK and MAINZ, Germany, October 19, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech…